Medico Remedies Limited
NSE: MEDICO BSE: MEDICO
NSE
49.77
-0.28 (-0.56%)
Prev Close
50.05
Open Price
49.51
Volume
68,407
Today Low / High
49.5 / 50.49
52 WK Low / High
37.18 / 79.83
Range
47 - 52
BSE
49.92
-0.23 (-0.46%)
Prev Close
50.15
Open Price
49.57
Volume
984
Today Low / High
49.27 / 49.92
52 WK Low / High
35 / 79.78
Range
47 - 52
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 49.77 (target range: 47 - 52), reflecting a change of -0.28 (-0.55944%). On the BSE, it is listed at 49.92 (target range: 47 - 52), showing a change of -0.23 (-0.45862%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
02 Jan
52.00
-3.13%
01 Jan
50.92
-3.44%
31 Dec
51.79
-2.30%
30 Dec
53.60
-4.94%
29 Dec
52.01
0.92%
26 Dec
55.77
-5.45%
24 Dec
56.00
-3.14%
23 Dec
48.55
10.98%
22 Dec
49.70
-1.43%
19 Dec
49.40
0.67%
18 Dec
50.21
-1.08%
17 Dec
49.85
-1.24%
16 Dec
50.00
-0.30%
15 Dec
52.30
-3.54%
12 Dec
50.00
2.64%
11 Dec
51.70
-1.41%
10 Dec
52.00
-0.87%
Medico Remedies Limited Graph
Medico Remedies Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Medico Remedies Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 49.77, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 49.92 | 50.42 | 45.38 - 55.46 |
| 50.92 | 40.73 - 61.10 | ||
| 51.42 | 35.99 - 66.84 | ||
| Bearish Scenario | 49.92 | 49.42 | 44.48 - 54.36 |
| 48.92 | 39.14 - 58.71 | ||
| 48.42 | 33.90 - 62.95 |
Overview of Medico Remedies Limited
ISIN
INE630Y01024
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
228,267
Market Cap
4,179,904,080
Last Dividend
0
Official Website
IPO Date
2022-05-26
DCF Diff
41.76
DCF
9
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 150.94 Cr | 108.33 Cr | 42.61 Cr | 0.2823 | 0.00 Cr | 4.43 Cr | 36.33 Cr | 10.09 Cr | 1.22 | 15.00 Cr | 0.0669 |
| 2024-03-31 | 144.92 Cr | 127.40 Cr | 17.52 Cr | 0.1209 | 0.00 Cr | 5.92 Cr | 10.17 Cr | 8.29 Cr | 1.00 | 17.74 Cr | 0.0572 |
| 2023-03-31 | 140.44 Cr | 104.87 Cr | 35.57 Cr | 0.2533 | 0.00 Cr | 2.72 Cr | 6.98 Cr | 7.24 Cr | 0.87 | 13.57 Cr | 0.0516 |
| 2022-03-31 | 121.02 Cr | 95.72 Cr | 17.67 Cr | 0.1460 | 0.00 Cr | 3.00 Cr | 5.22 Cr | 4.81 Cr | 0.58 | 9.33 Cr | 0.0398 |
| 2021-03-31 | 122.39 Cr | 98.98 Cr | 23.41 Cr | 0.1913 | 0.00 Cr | 2.77 Cr | 3.61 Cr | 2.59 Cr | 0.31 | 6.26 Cr | 0.0212 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.09 Cr | 119.80 Cr | 57.33 Cr | 62.4689 Cr | 14.70 Cr | 13.60 Cr | 26.73 Cr | 21.58 Cr | 0.00 Cr | 0.00 Cr | 0.20 Cr | 56.9615 Cr |
| 2024-03-31 | 0.18 Cr | 96.20 Cr | 43.82 Cr | 52.3710 Cr | 8.05 Cr | 7.87 Cr | 16.34 Cr | 21.37 Cr | 1.40 Cr | -0.14 Cr | 0.20 Cr | 42.8143 Cr |
| 2023-03-31 | 0.91 Cr | 87.45 Cr | 43.61 Cr | 43.8430 Cr | 9.76 Cr | 8.85 Cr | 19.70 Cr | 21.83 Cr | 0.43 Cr | 0.00 Cr | -0.49 Cr | 41.7700 Cr |
| 2022-03-31 | 1.17 Cr | 76.19 Cr | 38.87 Cr | 37.3200 Cr | 12.60 Cr | 8.27 Cr | 18.11 Cr | 16.10 Cr | 0.14 Cr | 0.00 Cr | 0.00 Cr | 38.1398 Cr |
| 2021-03-31 | 2.83 Cr | 75.62 Cr | 43.16 Cr | 32.4578 Cr | 15.05 Cr | 12.22 Cr | 14.55 Cr | 15.31 Cr | 1.81 Cr | 0.10 Cr | 0.11 Cr | 37.9542 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.8921 Cr | -3.4599 Cr | -0.5200 Cr | 1.7074 Cr | 0.9122 Cr | 1.0949 Cr | -3.1847 Cr | 10.0932 Cr | -0.5200 Cr | 0.0000 Cr | -10.3892 Cr |
| 2024-03-31 | 2.4379 Cr | -2.6766 Cr | -0.4900 Cr | 0.2044 Cr | -0.7287 Cr | 0.1827 Cr | -2.4783 Cr | 8.2909 Cr | -1.3415 Cr | 0.0000 Cr | 3.3615 Cr |
| 2023-03-31 | 8.1672 Cr | -6.6035 Cr | -1.8173 Cr | 1.5749 Cr | -0.2536 Cr | 0.9114 Cr | -6.5923 Cr | 7.2415 Cr | -1.2182 Cr | 0.0000 Cr | -1.5910 Cr |
| 2022-03-31 | 5.8620 Cr | -1.7564 Cr | -5.7710 Cr | -1.1500 Cr | -1.6654 Cr | 6.2500 Cr | -2.8600 Cr | 4.8900 Cr | -3.0988 Cr | 0.0000 Cr | -3.5600 Cr |
| 2021-03-31 | -11.3100 Cr | -16.9600 Cr | 18.2800 Cr | 0.4721 Cr | -9.9900 Cr | 2.8304 Cr | -2.1360 Cr | 2.5917 Cr | 4.9500 Cr | 0.0000 Cr | 3.7087 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 52.64 Cr | 40.44 Cr | 12.19 Cr | 0.2316 | 1.98 Cr | 2.57 Cr | 0.31 | 4.44 Cr | 0.0488 |
| 2025-06-30 | 38.25 Cr | 27.34 Cr | 10.91 Cr | 0.2853 | 2.06 Cr | 1.82 Cr | 0.22 | 3.48 Cr | 0.0475 |
| 2025-03-31 | 41.30 Cr | 27.36 Cr | 13.94 Cr | 0.3375 | 12.36 Cr | 4.34 Cr | 0.52 | 6.66 Cr | 0.1051 |
| 2024-12-31 | 39.49 Cr | 28.66 Cr | 10.83 Cr | 0.2742 | 2.35 Cr | 2.62 Cr | 0.32 | 4.54 Cr | 0.0663 |
| 2024-09-30 | 39.35 Cr | 30.25 Cr | 9.10 Cr | 0.2313 | 1.67 Cr | 1.55 Cr | 0.19 | 3.09 Cr | 0.0395 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.27 Cr | 1.50 Cr | 1.76 Cr | 57.66 Cr | 41.38 Cr | 113.80 Cr | 21.27 Cr | 137.36 Cr | 70.50 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 2.55 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -62.47 Cr |
| 2025-03-31 | 1.09 Cr | 1.45 Cr | 2.55 Cr | 57.18 Cr | 26.73 Cr | 96.68 Cr | 21.58 Cr | 119.80 Cr | 57.33 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1.52 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -55.51 Cr |
| 2024-09-30 | 0.12 Cr | 1.41 Cr | 1.52 Cr | 0.20 Cr | 17.05 Cr | 77.02 Cr | 20.94 Cr | 99.04 Cr | 43.53 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1.82 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 4.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 2.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 1.55 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2023-03-16 | March 16, 23 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,761.70 | ₹4,226,908,416,649.00 | ₹1,472,684.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,649.00 | ₹1,765,100,588,420.00 | ₹672,729.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,933.50 | ₹1,331,275,138,240.00 | ₹159,854.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,256.30 | ₹1,045,885,485,158.00 | ₹474,864.00 |
| Lupin Limited | LUPIN | ₹2,152.80 | ₹983,396,469,557.00 | ₹1,450,118.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹929.75 | ₹935,546,052,203.00 | ₹340,641.00 |
| Mankind Pharma Limited | MANKIND | ₹2,240.30 | ₹924,807,202,802.00 | ₹236,960.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,233.00 | ₹716,128,401,159.00 | ₹1,687,647.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,658.00 | ₹676,498,770,000.00 | ₹74,886.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,115.90 | ₹602,425,959,854.00 | ₹1,054,080.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,074.60 | ₹585,453,798,351.00 | ₹186,001.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,470.00 | ₹372,945,200,460.00 | ₹585,877.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,846.80 | ₹355,666,734,403.00 | ₹279,657.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,879.00 | ₹294,347,146,324.00 | ₹211,140.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,530.10 | ₹290,064,943,454.00 | ₹281,696.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,467.00 | ₹238,376,011,923.00 | ₹901,810.00 |
| Eris Lifesciences Limited | ERIS | ₹1,552.50 | ₹211,476,723,278.00 | ₹31,549.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,407.00 | ₹210,175,000,000.00 | ₹37,561.00 |
| Cohance Lifesciences Limited | COHANCE | ₹503.45 | ₹192,603,426,633.00 | ₹402,100.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹14,520.00 | ₹186,289,988,280.00 | ₹66,617.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,080.40 | ₹171,241,709,174.00 | ₹154,663.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹925.75 | ₹165,810,962,153.00 | ₹1,143,584.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹826.80 | ₹162,518,390,923.00 | ₹53,139.00 |
| Granules India Limited | GRANULES | ₹613.00 | ₹148,755,922,908.00 | ₹481,822.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,842.80 | ₹140,074,353,389.00 | ₹31,582.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹907.60 | ₹111,345,591,445.00 | ₹34,897.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,795.50 | ₹96,201,718,381.00 | ₹4,150.00 |
| Strides Pharma Science Limited | STAR | ₹987.35 | ₹91,006,729,168.00 | ₹1,033,249.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹443.95 | ₹67,969,658,649.00 | ₹54,474.00 |
| FDC Limited | FDC | ₹412.55 | ₹67,167,300,154.00 | ₹92,294.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹736.30 | ₹66,743,602,572.00 | ₹83,116.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹318.25 | ₹62,243,912,942.00 | ₹104,610.00 |
| Sequent Scientific Limited | SEQUENT | ₹206.80 | ₹51,663,565,769.00 | ₹340,926.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹420.50 | ₹45,819,893,933.00 | ₹29,638.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹136.29 | ₹44,229,047,229.00 | ₹844,523.00 |
| Innova Captab Limited | INNOVACAP | ₹728.50 | ₹41,688,360,777.00 | ₹9,669.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹782.70 | ₹39,697,843,484.00 | ₹40,095.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,332.90 | ₹38,583,868,094.00 | ₹2,487.00 |
| Suven Life Sciences Limited | SUVEN | ₹170.52 | ₹37,583,633,678.00 | ₹748,782.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹403.50 | ₹36,827,445,000.00 | ₹87,942.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹329.40 | ₹33,033,057,476.00 | ₹13,223.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹434.45 | ₹30,587,778,088.00 | ₹4,669.00 |
Key Executives
Chief Accountant
Rajesh C. Chawda
Gender: Not Specified
Year Born:
Head of Production Department (B-Lactum)
Akhilesh Singh
Gender: Not Specified
Year Born:
Chairman, Chief Financial Officer & Head of Legal
Haresh Kapurlal Mehta
Gender: male
Year Born: 1955
MD, Marketing & Export Head and Director
Harshit Haresh Mehta
Gender: male
Year Born: 1985
Executive Director
Maheshkumar Darji
Gender: male
Year Born: 1976
Production of Technical & Quality Control Head and Whole-Time Director
Rishit Hareshbhai Mehta
Gender: male
Year Born: 1988
Head of the Production Department - General
Nilesh Misal
Gender: Not Specified
Year Born:
FAQs about Medico Remedies Limited
Who is the CEO of the company?
The CEO is Haresh Kapurlal Mehta.
What is the current market price of the stock?
The current price is ₹50.37.
What is the 52-week price range?
The range is ₹37.18-79.83.
What is the market capitalization of the company?
The market capitalization is ₹417.99 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 36.78.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Medico Remedies Limited (ISIN: INE630Y01024) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹417.99 crores and an average daily volume of 228,267 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.